SCHEMBL3170848

SCHEMBL3170848

CC(=O)NCCNc1cc(N2CCN(C(=O)Cc3ccccc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.52
KDM6B O15054 3/20 0.46
KDM2B Q8NHM5 3/20 0.46
CHRNA1 P02708 2/20 0.46
MAOB P27338 2/20 0.46
OPRM1 P35372 2/20 0.46
OPRK1 P41145 2/20 0.46
PDE4B Q07343 2/20 0.46
SCN5A Q14524 2/20 0.46
KDM4C Q9H3R0 2/20 0.46
KDM5B Q9UGL1 2/20 0.46
PHF8 Q9UPP1 2/20 0.46
NR1I2 O75469 1/20 0.46
AHR P35869 1/20 0.46
AVPR1A P37288 1/20 0.46
SLCO1B1 Q9Y6L6 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
ADORA2B P29275 3/20 0.45
ADORA3 P0DMS8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3172646 0.96 GBA1 (0.48) GBA1KDM6BKDM2BCHRNA1MAOB
SCHEMBL3172993 0.95 SMN1; SMN2 (0.50) GBA1KDM6BKDM2BCHRNA1MAOB
SCHEMBL3164879 0.94 GBA1 (0.48) GBA1KDM6BKDM2BCHRNA1MAOB
SCHEMBL3164817 0.94 KDM4E (0.49) GBA1KDM6BKDM2BCHRNA1MAOB
SCHEMBL3174442 0.93 GBA1 (0.47) GBA1KDM6BKDM2BCHRNA1MAOB
SCHEMBL3175770 0.92 L3MBTL1 (0.52) GBA1ALDH1A1LMNAADORA3KMT2A
SCHEMBL3164902 0.92 GFER (0.47) GBA1KDM6BKDM2BCHRNA1MAOB
SCHEMBL3176585 0.91 GBA1 (0.43) GBA1KDM6BKDM2BCHRNA1MAOB
SCHEMBL3164906 0.91 KDM6B (0.45) GBA1KDM6BKDM2BCHRNA1MAOB
SCHEMBL3177354 0.91 KMT2A (0.49) GBA1KDM6BKDM2BCHRNA1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed